XPA, XPC, and XPD Modulate Sensitivity in Gastric Cisplatin Resistance Cancer Cells

Cisplatin is an election drug widely used in clinic for the treatment of advanced gastric cancer. However, the heterogeneity of the gastric tumors and its resistance to the drugs, make in some cases the response very low and the prognosis unpredictable. In this manuscript we aim to find the molecula...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Pharmacol
Autors principals: Pajuelo-Lozano, Natalia, Bargiela-Iparraguirre, Jone, Dominguez, Gemma, Quiroga, Adoracion G., Perona, Rosario, Sanchez-Perez, Isabel
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2018
Matèries:
Pharmacology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6199368/
https://ncbi.nlm.nih.gov/pubmed/30386247
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2018.01197
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars